Results 131 to 140 of about 15,417 (291)

Primary sebaceous gland carcinoma of pinna

open access: yesIndian Journal of Dermatology, 2009
Sebaceous gland carcinoma is a rare cancer most commonly seen in the meibomian glands of the eyelid. It has predilection for periocular region and is rarely found in extra ocular sites.
Agarwal Akhilesh   +3 more
doaj  

SMILE: Extraction‐free submicron‐resolution mapping of lipid chain length and unsaturation by stimulated Raman imaging

open access: yesVIEW, EarlyView.
In this work, we develop submicron‐resolution mapping of intracellular lipid elements (SMILE) as an extraction‐free vibrational spectroscopic imaging platform based on hyperspectral stimulated Raman scattering microscopy with a spectral analysis pipeline for pixel‐resolved lipid profiling.
Yihui Zhou   +10 more
wiley   +1 more source

Peptide‐directed nanovehicles enabling tumor‐selective ROS amplification and antitumor immunity

open access: yesVIEW, EarlyView.
Cancer cells are vulnerable to oxidative stress, yet exploit immune tolerance to escape destruction. In contrast, their metabolic profile is markedly altered to support rapid proliferation, accompanied by elevated production of reactive oxygen species (ROS).
Manuela Calin   +3 more
wiley   +1 more source

SEBACEOUS CARCINOMA OF PAROTID GLAND

open access: yesGomal Journal of Medical Sciences, 2014
Sebaceous carcinoma is a very rare tumor of the salivary glands with most of the reported cases involving the parotid gland. We report a case of sebaceous carcinoma of right parotid gland of a 51 year old female patient diagnosed on histopathological ...
Krishnendu Das, Arindam Karmakar
doaj  

Risk Factors for Cutaneous Immune‐Related Adverse Events in the Japanese Population: A Retrospective Single‐Center Cohort Study

open access: yesThe Journal of Dermatology, EarlyView.
ABSTRACT Immune checkpoint inhibitor (ICI)‐driven alterations in the immune system can induce immune‐related adverse events (irAEs). Cutaneous irAEs are notable for being the most common and for their early onset; however, the risk factors underlying their development and severity remain unclear. In this study, we retrospectively analyzed 1224 Japanese
Tomoya Watanabe   +4 more
wiley   +1 more source

Interventional oncology in children: Where are we now?

open access: yesJournal of Medical Imaging and Radiation Oncology, EarlyView.
Abstract Paediatric Interventional Oncology (IO) lags behind adult IO due to a scarcity of specific outcome data. The suboptimal way to evolve this field is relying heavily on adult experiences. The distinct tumour types prevalent in children, such as extracranial germ cell tumours, sarcomas, and neuroblastoma, differ strongly from those found in ...
Premal Amrishkumar Patel   +1 more
wiley   +1 more source

What anabolic–androgenic steroids reveal about the limits of current harm reduction models

open access: yesAddiction, EarlyView.
Abstract Background Harm reduction has largely been shaped by responses to psychoactive drug use where the most urgent harms are acute. These models focus on overdose, blood‐borne viruses, and rapid‐onset toxicity related harms. When applied wholesale to anabolic–androgenic steroids (AAS), they obscure the distinctive pharmacology, consumer typologies,
Timothy Piatkowski   +2 more
wiley   +1 more source

Recurrence of Breast Cancer With Scalp Metastasis

open access: yes
The Kaohsiung Journal of Medical Sciences, EarlyView.
Yi‐Nan Zhu   +3 more
wiley   +1 more source

The Rintala Advanced Modification (RAM) Flap: A Novel Technique for Off‐Centre Nasal Reconstruction

open access: yesAustralasian Journal of Dermatology, EarlyView.
ABSTRACT The traditional Rintala flap is associated with visible forehead scarring and glabellar deformities. We describe the Rintala Advanced Modification (RAM) flap, a novel technique that restricts the flap below the eyebrow line and employs asymmetric Burow's triangles for off‐centre defects.
Ramy Awadalla, Derek Davies
wiley   +1 more source

Extraocular Sebaceous Carcinoma of the Scalp in an Elderly Patient. [PDF]

open access: yesCureus
Rompou AV   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy